Trial · NCT05295784
Registered outcomes11
Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.
1 to 11 of 11
Download this page as JSON| List | Outcome | Time frame | Description |
|---|---|---|---|
| Primary | Clearance of caffeine | 1 week | Clearance (mL h-1 kg-1) |
| Primary | Volume of distribution of caffeine | 1 week | Volume of distribution (ml/kg) |
| Primary | Peak plasma concentration (Cmax) of caffeine | 1 week | Peak plasma concentration (Cmax) (ng/mL) |
| Primary | Area under the plasma concentration-time curve of caffeine | 1 week | Area under the plasma concentration-time curve from 0 to infinity (AUC0-INF) (mg\*h/L) |
| Primary | Seizure incidence | 2 weeks | Number of neonates who developed seizures based on continuous video electroencephalogram (VEEG) data |
| Primary | Seizure burden | 2 weeks | Electrographic seizures (in minutes per hour) based on continuous video electroencephalogram (VEEG) data |
| Secondary | Acute kidney injury | 10 days | AKI incidence utilizing KDIGO criteria based on urine output and SCr. |
| Secondary | Renal near infrared spectroscopy (NIRS) | 5 days | Investigate changes in renal NIRS values during the therapeutic hypothermia and rewarming period. |
| Secondary | Urine neutrophil gelatinase-associated lipocalin (NGAL) (ng/mL) | 3 days | Urine samples will be collected at 24, 48 and 72 hours after birth. Urine will be analyzed for NGAL. |
| Secondary | Urine kidney injury molecule-1 (KIM-1) (pg/mL) | 3 days | Urine samples will be collected at 24, 48 and 72 hours after birth. Urine will be analyzed for KIM-1. |
| Secondary | Urine interleukin-18 (IL-18) (pg/mL) | 3 days | Urine samples will be collected at 24, 48 and 72 hours after birth. Urine will be analyzed for IL-18. |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT05295784/registered